Dr. Susanne Saussele studied medicine at the University of Heidelberg and specialised in internal medicine and haematology/oncology. She did her thesis in the laboratory of Prof. Dr. R. Hehlmann. Currently, she is Chief Executive of the German Competence Net “Acute and chronic leukemias”. She is also active as Scientific Network Manager of the European LeukemiaNet (ELN, founded 2004 as a Network of Excellence within the 6th framework of the European Commission), is CEO of the German foundation “Stiftung Leukämie” and the international “ELN Foundation”. Since 2007, she has been Group Leader of the study centre of the German CML Study Group at the III. Medizinische Klinik Mannheim, University of Heidelberg and Sub-project Leader for the “Spread of Excellence” group of the “European Treatment Outcome Study for CML (EUTOS)”. Since 2012 she is also main investigator of the international study for TKI treatment discontinuation (EuroSKI). Her research interests focus on leukemia, in particular CML, allogeneic stem cell transplantation and health-related quality of life of CML patients.
Biography Updated on 11 March 2013